XML 40 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions (Tables)
9 Months Ended
Sep. 30, 2018
Business Acquisition [Line Items]  
Business Acquisition, Pro Forma Information
The following table summarizes our consolidated results of operations for the nine-month period ended September 30, 2017, as well as unaudited pro forma consolidated results of operations as though the acquisition of the Argon critical care division had occurred on January 1, 2016 (in thousands, except per common share amounts):

Nine Months Ended 
September 30, 2017
As Reported Pro Forma 
Net sales $536,955 $539,715 
Net income 20,717 10,039 
Earnings per common share: 
Basic $0.43 $0.21 
Diluted $0.42 $0.20 
* The pro forma results for the three-month periods ended September 30, 2018 and 2017 and the nine-month period ended September 30, 2018 are not included in the table above because the operating results for the Argon critical care division acquisition were included in our consolidated statements of income for these periods.
DirectACCESS Medical, LLC  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The purchase price was preliminarily allocated as follows (in thousands):
Inventories
$971 
Intangibles
Developed technology
4,840 
Customer list
120 
Trademarks
400 
Goodwill
938 
Total assets acquired $7,269 
Becton, Dickinson and Company  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The following table summarizes the purchase price allocated to the assets acquired from BD (in thousands):
Inventories
$5,804 
Property and equipment
748 
Intangibles
Developed technology
74,000 
Customer list
4,200 
Trademarks
4,900 
Goodwill
10,613 
Total assets acquired $100,265 
ITL Healthcare Pty Ltd  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The following table summarizes the aggregate purchase price allocated to the assets acquired from ITL (in thousands):
Assets Acquired 
Trade receivables
$1,287 
Other receivables
56 
Inventories
1,808 
Prepaid expenses and other assets
65 
Property and equipment
1,053 
Intangibles
Customer lists
5,940 
Goodwill
3,945 
Total assets acquired 14,154 
Liabilities Assumed 
Trade payables
(216)
Accrued expenses
(747)
Deferred income tax liabilities
(1,901)
Total liabilities assumed (2,864)
Total net assets acquired $11,290 
Laurane Medical S.A.S.  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The following table summarizes the aggregate purchase price (including contingent royalty payment liabilities) allocated to the assets acquired from Laurane (in thousands):
Inventories
$594 
Intangibles
Developed technology
14,920 
Customer list 120 
Goodwill 6,366 
Total assets acquired $22,000 
Osseon LLC  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The following table summarizes the purchase price allocated to the assets acquired (in thousands):
Inventories $979 
Property and equipment 58 
Intangibles 
Developed technology 5,400 
Customer list 200 
Goodwill 203 
Total assets acquired $6,840 
Vascular Access Technologies, Inc.  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The following table summarizes the purchase price allocated to the net assets acquired (in thousands):
Intangibles 
Developed technology $7,800 
In-process technology 920 
Goodwill 4,281 
Deferred tax liabilities (3,101)
Total net assets acquired $9,900 
Argon Medical Devices, Inc.  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The following table summarizes the purchase price allocated to the net tangible and intangible assets acquired and liabilities assumed (in thousands):
Assets Acquired
Cash and cash equivalents $1,436 
Trade receivables 8,351 
Inventories 11,222 
Prepaid expenses and other assets 1,275 
Income tax refund receivables 165 
Property and equipment 2,319 
Deferred income tax assets 202 
Intangibles 
Developed technology 2,200 
Customer lists 1,500 
Trademarks 900 
Total assets acquired 29,570 
Liabilities Assumed 
Trade payables (2,414)
Accrued expenses (5,083)
Deferred income tax liabilities (934)
Total liabilities assumed (8,431)
Total net assets acquired 21,139 
Gain on bargain purchase (1)
(11,039)
Total purchase price $10,100 
(1)
The total fair value of the net assets acquired from Argon exceeded the purchase price, resulting in a gain on bargain purchase which was recorded within other income (expense) in our consolidated statements of income. We believe the reason for the gain on bargain purchase was a result of the divestiture of a non-strategic, slow-growth critical care business for Argon. It is our understanding that the divestiture allows Argon to focus on its higher growth interventional portfolio. A reduction of $1.2 million was recorded since the bargain purchase gain was first presented in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, resulting from our ongoing activities, including reassessment of the assets acquired and liabilities assumed. The purchase price allocation for this acquisition is now final.
Catheter Connections, Inc.  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The purchase price was allocated as follows (in thousands):
Assets Acquired 
Trade receivables $958 
Inventories 2,157 
Prepaid expenses and other assets 85 
Property and equipment 1,472 
Intangibles 
Developed technology 21,100 
Customer lists 700 
Trademarks 2,900 
Goodwill 8,989 
Total assets acquired 38,361 
Liabilities Assumed 
Trade payables (338)
Accrued expenses (23)
Total liabilities assumed (361)
Total net assets acquired $38,000